skinny.

Latest / GK Daily Podcast

GK Daily Special Edition: The Thermostat in Your Brain — How a New Pill Is Rewriting Menopause Care

Elinzanetant (Lynkuet) is the first approved drug to block both NK1 and NK3 receptors, approved by the FDA in October 2025 for moderate to severe menopausal hot flashes. This episode covers the KNDy-neuron biology behind hot flashes, the OASIS trial data, cost, how it compares with fezolinetant, liver monitoring, and the FDA’s pending review of its use in women with breast cancer.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.